Cited 0 time in
The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, Je-Min | - |
| dc.contributor.author | Bothwell, Alfred L. M. | - |
| dc.date.accessioned | 2022-07-16T16:22:04Z | - |
| dc.date.available | 2022-07-16T16:22:04Z | - |
| dc.date.issued | 2012-03 | - |
| dc.identifier.issn | 1016-8478 | - |
| dc.identifier.issn | 0219-1032 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/166149 | - |
| dc.description.abstract | Members of the nuclear receptor superfamily function as transcription factors involved in innate and adaptive immunity as well as lipid metabolism. These highly conserved proteins participate in ligand-dependent or -independent regulatory mechanisms that affect gene expression. Peroxisome proliferator-activated receptors (PPARs), which include PPAR alpha, PPAR beta/delta, and PPAR gamma, are a group of nuclear receptor proteins that play diverse roles in cellular differentiation, development, and metabolism. Each PPAR subfamily is activated by different endogenous and synthetic ligands. Recent studies using specific ligand treatments and cell type-specific PPAR knockout mice have revealed important roles for these proteins in T-cell-related autoimmune diseases. Moreover, PPARs have been shown to regulate T-cell survival, activation, and CD4(+) T helper cell differentiation into the Th1, Th2, Th17, and Treg lineages. Here, we review the studies that provide insight into the important regulatory roles of PPARs in T-cell activation, survival, proliferation, differentiation, and autoimmune disease. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 한국분자세포생물학회 | - |
| dc.title | The Nuclear Receptor PPARs as Important Regulators of T-Cell Functions and Autoimmune Diseases | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.1007/s10059-012-2297-y | - |
| dc.identifier.scopusid | 2-s2.0-84863448693 | - |
| dc.identifier.wosid | 000302818700001 | - |
| dc.identifier.bibliographicCitation | Molecules and Cells, v.33, no.3, pp 217 - 222 | - |
| dc.citation.title | Molecules and Cells | - |
| dc.citation.volume | 33 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 217 | - |
| dc.citation.endPage | 222 | - |
| dc.type.docType | Review | - |
| dc.identifier.kciid | ART001642309 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | PROLIFERATOR-ACTIVATED-RECEPTOR | - |
| dc.subject.keywordPlus | LIGAND-BINDING DOMAIN | - |
| dc.subject.keywordPlus | GENE-EXPRESSION | - |
| dc.subject.keywordPlus | GAMMA AGONISTS | - |
| dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
| dc.subject.keywordPlus | FATTY-ACIDS | - |
| dc.subject.keywordPlus | ALPHA | - |
| dc.subject.keywordPlus | INFLAMMATION | - |
| dc.subject.keywordPlus | INHIBIT | - |
| dc.subject.keywordPlus | TRANSREPRESSION | - |
| dc.subject.keywordAuthor | autoimmune disease | - |
| dc.subject.keywordAuthor | nuclear receptor | - |
| dc.subject.keywordAuthor | PPAR | - |
| dc.subject.keywordAuthor | T cell | - |
| dc.identifier.url | https://link.springer.com/article/10.1007/s10059-012-2297-y | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
